The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis

R. Cabrera (Barcelona, Spain), L. Fernández-Barat (Barcelona, Spain), N. Vázquez (Barcelona, Spain), V. Alcaráz (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Amaro (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), L. Muñoz (Barcelona, Spain), J. Vila (Barcelona, Spain), A. Torres (Barcelona, Spain)

Source: Virtual Congress 2021 – Back to infection basics
Session: Back to infection basics
Session type: E-poster
Number: 2359

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Cabrera (Barcelona, Spain), L. Fernández-Barat (Barcelona, Spain), N. Vázquez (Barcelona, Spain), V. Alcaráz (Barcelona, Spain), R. López-Aladid (Barcelona, Spain), L. Bueno (Barcelona, Spain), R. Amaro (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), L. Muñoz (Barcelona, Spain), J. Vila (Barcelona, Spain), A. Torres (Barcelona, Spain). The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis. 2359

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Macrolide resistance in Pseudomonas aeruginosa: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017



Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients
Source: Eur Respir J, 49 (5) 1601847; 10.1183/13993003.01847-2016
Year: 2017



Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017

Comparative in vitro activity of fluoroquinolones against P. aeruginosa isolated from Greek CF patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003



The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of S. aureus and haemophilus
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006


Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011



Uncommon accumulation of multidrug resistance and virulence potential in carbapenemase ST-14 KPC-3 Klebsiella pneumoniae in Portugal: a high risk threat
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018

Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004

Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis
Source: Eur Respir J 2013; 42: 1723-1736
Year: 2013



Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008



Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006